{
"info": {
"nct_id": "NCT00008073",
"official_title": "Phase I Study Of Octreotide Acetate (Sandostatin) (SMS) As A Biomodulator Of Doxorubicin (DOX)",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS: Histologically confirmed malignancy ineligible for therapy of proven greater benefit than doxorubicin alone Measurable or evaluable disease\n\nPATIENT CHARACTERISTICS: Age: 18 and over Performance status: ECOG 0-2 Life expectancy: Not specified Hematopoietic: WBC at least 3,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 2 mg/dL SGOT no greater than 4 times normal Renal: Creatinine no greater than 2 mg/dL Cardiovascular: LVEF at least 50% No compensated or uncompensated congestive heart failure Other: Not pregnant Fertile patients must use effective contraception during and for 2 months after study No history of gallstones with gallbladder in place\n\nPRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease Characteristics At least 3 weeks since prior chemotherapy (6 weeks for mitomycin or nitrosourea) and recovered No more than 240 mg/m2 total cumulative dose of prior doxorubicin Endocrine therapy: Prior octreotide allowed Recovered from prior octreotide Radiotherapy: At least 3 weeks since prior radiotherapy and recovered Surgery: Not specified"
},
"inclusion_lines": [
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"identified_line": {
"line": "PATIENT CHARACTERISTICS: Age: 18 and over Performance status: ECOG 0-2 Life expectancy: Not specified Hematopoietic: WBC at least 3,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 2 mg/dL SGOT no greater than 4 times normal Renal: Creatinine no greater than 2 mg/dL Cardiovascular: LVEF at least 50% No compensated or uncompensated congestive heart failure Other: Not pregnant Fertile patients must use effective contraception during and for 2 months after study No history of gallstones with gallbladder in place",
"criterions": [
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": true
}
},
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirement": {
"requirement_type": "age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "Performance status: ECOG 0-2",
"criterion": "performance status",
"requirement": {
"requirement_type": "scale",
"expected_value": "ECOG"
}
},
{
"exact_snippets": "Performance status: ECOG 0-2",
"criterion": "performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
},
{
"exact_snippets": "Life expectancy: Not specified",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "specification",
"expected_value": "Not specified"
}
},
{
"exact_snippets": "Hematopoietic: WBC at least 3,500/mm3",
"criterion": "WBC",
"requirement": {
"requirement_type": "minimum count",
"expected_value": {
"operator": ">=",
"value": 3500,
"unit": "mm3"
}
}
},
{
"exact_snippets": "Platelet count at least 100,000/mm3",
"criterion": "platelet count",
"requirement": {
"requirement_type": "minimum count",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm3"
}
}
},
{
"exact_snippets": "Hepatic: Bilirubin no greater than 2 mg/dL",
"criterion": "bilirubin",
"requirement": {
"requirement_type": "maximum level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "mg/dL"
}
}
},
{
"exact_snippets": "SGOT no greater than 4 times normal",
"criterion": "SGOT",
"requirement": {
"requirement_type": "maximum level",
"expected_value": "no greater than 4 times normal"
}
},
{
"exact_snippets": "Renal: Creatinine no greater than 2 mg/dL",
"criterion": "creatinine",
"requirement": {
"requirement_type": "maximum level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "mg/dL"
}
}
},
{
"exact_snippets": "Cardiovascular: LVEF at least 50%",
"criterion": "LVEF",
"requirement": {
"requirement_type": "minimum percentage",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
},
{
"exact_snippets": "No compensated or uncompensated congestive heart failure",
"criterion": "congestive heart failure",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "Fertile patients must use effective contraception during and for 2 months after study",
"criterion": "contraception",
"requirement": {
"requirement_type": "usage",
"expected_value": "effective contraception during and for 2 months after study"
}
},
{
"exact_snippets": "No history of gallstones with gallbladder in place",
"criterion": "history of gallstones with gallbladder in place",
"requirement": {
"requirement_type": "history",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": true
}
},
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirement": {
"requirement_type": "age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Performance status: ECOG 0-2",
"criterion": "performance status",
"requirement": {
"requirement_type": "scale",
"expected_value": "ECOG"
}
},
{
"exact_snippets": "Performance status: ECOG 0-2",
"criterion": "performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
}
]
},
{
"exact_snippets": "Life expectancy: Not specified",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "specification",
"expected_value": "Not specified"
}
},
{
"exact_snippets": "Hematopoietic: WBC at least 3,500/mm3",
"criterion": "WBC",
"requirement": {
"requirement_type": "minimum count",
"expected_value": {
"operator": ">=",
"value": 3500,
"unit": "mm3"
}
}
},
{
"exact_snippets": "Platelet count at least 100,000/mm3",
"criterion": "platelet count",
"requirement": {
"requirement_type": "minimum count",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm3"
}
}
},
{
"exact_snippets": "Hepatic: Bilirubin no greater than 2 mg/dL",
"criterion": "bilirubin",
"requirement": {
"requirement_type": "maximum level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "mg/dL"
}
}
},
{
"exact_snippets": "SGOT no greater than 4 times normal",
"criterion": "SGOT",
"requirement": {
"requirement_type": "maximum level",
"expected_value": "no greater than 4 times normal"
}
},
{
"exact_snippets": "Renal: Creatinine no greater than 2 mg/dL",
"criterion": "creatinine",
"requirement": {
"requirement_type": "maximum level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "mg/dL"
}
}
},
{
"exact_snippets": "Cardiovascular: LVEF at least 50%",
"criterion": "LVEF",
"requirement": {
"requirement_type": "minimum percentage",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
},
{
"exact_snippets": "No compensated or uncompensated congestive heart failure",
"criterion": "congestive heart failure",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "Fertile patients must use effective contraception during and for 2 months after study",
"criterion": "contraception",
"requirement": {
"requirement_type": "usage",
"expected_value": "effective contraception during and for 2 months after study"
}
},
{
"exact_snippets": "No history of gallstones with gallbladder in place",
"criterion": "history of gallstones with gallbladder in place",
"requirement": {
"requirement_type": "history",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease Characteristics At least 3 weeks since prior chemotherapy (6 weeks for mitomycin or nitrosourea) and recovered No more than 240 mg/m2 total cumulative dose of prior doxorubicin Endocrine therapy: Prior octreotide allowed Recovered from prior octreotide Radiotherapy: At least 3 weeks since prior radiotherapy and recovered Surgery: Not specified",
"criterions": [
{
"exact_snippets": "At least 3 weeks since prior chemotherapy",
"criterion": "time since prior chemotherapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
},
{
"exact_snippets": "6 weeks for mitomycin or nitrosourea",
"criterion": "time since prior mitomycin or nitrosourea",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior chemotherapy",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
},
{
"exact_snippets": "No more than 240 mg/m2 total cumulative dose of prior doxorubicin",
"criterion": "total cumulative dose of prior doxorubicin",
"requirement": {
"requirement_type": "dose",
"expected_value": {
"operator": "<=",
"value": 240,
"unit": "mg/m2"
}
}
},
{
"exact_snippets": "Prior octreotide allowed",
"criterion": "prior octreotide",
"requirement": {
"requirement_type": "allowance",
"expected_value": true
}
},
{
"exact_snippets": "Recovered from prior octreotide",
"criterion": "recovery from prior octreotide",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
},
{
"exact_snippets": "At least 3 weeks since prior radiotherapy",
"criterion": "time since prior radiotherapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior radiotherapy",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "At least 3 weeks since prior chemotherapy",
"criterion": "time since prior chemotherapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior chemotherapy",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "6 weeks for mitomycin or nitrosourea",
"criterion": "time since prior mitomycin or nitrosourea",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior chemotherapy",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
}
]
},
{
"exact_snippets": "No more than 240 mg/m2 total cumulative dose of prior doxorubicin",
"criterion": "total cumulative dose of prior doxorubicin",
"requirement": {
"requirement_type": "dose",
"expected_value": {
"operator": "<=",
"value": 240,
"unit": "mg/m2"
}
}
},
{
"and_criteria": [
{
"exact_snippets": "Prior octreotide allowed",
"criterion": "prior octreotide",
"requirement": {
"requirement_type": "allowance",
"expected_value": true
}
},
{
"exact_snippets": "Recovered from prior octreotide",
"criterion": "recovery from prior octreotide",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "At least 3 weeks since prior radiotherapy",
"criterion": "time since prior radiotherapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
},
{
"exact_snippets": "recovered",
"criterion": "recovery from prior radiotherapy",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
}
]
}
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"identified_line": {
"line": "DISEASE CHARACTERISTICS: Histologically confirmed malignancy ineligible for therapy of proven greater benefit than doxorubicin alone Measurable or evaluable disease",
"criterions": [
{
"exact_snippets": "Histologically confirmed malignancy",
"criterion": "malignancy",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "ineligible for therapy of proven greater benefit than doxorubicin alone",
"criterion": "eligibility for therapy",
"requirement": {
"requirement_type": "eligibility",
"expected_value": "ineligible for therapy of proven greater benefit than doxorubicin alone"
}
},
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease measurability",
"requirement": {
"requirement_type": "measurability",
"expected_value": [
"measurable",
"evaluable"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Histologically confirmed malignancy",
"criterion": "malignancy",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "ineligible for therapy of proven greater benefit than doxorubicin alone",
"criterion": "eligibility for therapy",
"requirement": {
"requirement_type": "eligibility",
"expected_value": "ineligible for therapy of proven greater benefit than doxorubicin alone"
}
},
{
"or_criteria": [
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease measurability",
"requirement": {
"requirement_type": "measurability",
"expected_value": "measurable"
}
},
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease measurability",
"requirement": {
"requirement_type": "measurability",
"expected_value": "evaluable"
}
}
]
}
]
}
}
]
}